SRZN

Surrozen (SRZN)

Surrozen Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SRZN

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/12	21:30	GlobeNewswire Inc.	Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling	NASDAQ:SRZN	Surrozen Inc
2024/06/10	21:30	GlobeNewswire Inc.	Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan	NASDAQ:SRZN	Surrozen Inc
2024/06/04	21:30	GlobeNewswire Inc.	Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis	NASDAQ:SRZN	Surrozen Inc
2024/05/09	21:30	GlobeNewswire Inc.	Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting	NASDAQ:SRZN	Surrozen Inc
2024/05/09	05:05	GlobeNewswire Inc.	Surrozen Provides First Quarter 2024 Financial Results and Business Update	NASDAQ:SRZN	Surrozen Inc
2024/04/03	21:40	GlobeNewswire Inc.	Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis	NASDAQ:SRZN	Surrozen Inc
2024/04/01	21:30	GlobeNewswire Inc.	Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043	NASDAQ:SRZN	Surrozen Inc
2024/04/01	21:30	GlobeNewswire Inc.	Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules	NASDAQ:SRZN	Surrozen Inc
2024/02/07	20:16	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SRZN	Surrozen Inc
2024/02/07	20:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRZN	Surrozen Inc
2024/01/23	07:24	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SRZN	Surrozen Inc
2024/01/18	22:41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRZN	Surrozen Inc
2024/01/18	22:30	GlobeNewswire Inc.	Surrozen Provides Corporate Update on Clinical Programs	NASDAQ:SRZN	Surrozen Inc
2023/12/19	11:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SRZN	Surrozen Inc
2023/12/14	07:21	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SRZN	Surrozen Inc
2023/12/14	07:14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRZN	Surrozen Inc
2023/12/12	06:11	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SRZN	Surrozen Inc
2023/12/12	06:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRZN	Surrozen Inc
2023/11/09	06:27	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SRZN	Surrozen Inc
2023/11/09	06:17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SRZN	Surrozen Inc
2023/11/09	06:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRZN	Surrozen Inc
2023/11/09	06:05	GlobeNewswire Inc.	Surrozen Provides Third Quarter 2023 Financial Results	NASDAQ:SRZN	Surrozen Inc
2023/10/25	05:23	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SRZN	Surrozen Inc
2023/10/25	05:18	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SRZN	Surrozen Inc
2023/10/14	05:51	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SRZN	Surrozen Inc
2023/10/14	05:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRZN	Surrozen Inc
2023/08/24	06:17	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SRZN	Surrozen Inc
2023/08/10	05:39	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SRZN	Surrozen Inc
2023/08/10	05:25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SRZN	Surrozen Inc
2023/08/10	05:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRZN	Surrozen Inc